Liquid Biopsies for Cancer, Prostate Cancer Focal Therapy, EGFR-Mutated Non–Small Cell Lung Cancer Treatment, Author Use of AI in Medical Publication, and more
Summary
JAMA Deputy Editors Linda Brubaker and Preeti Malani review recent findings on EGFR-mutated lung cancer, anesthesia techniques, and prostate cancer treatments. They discuss workforce data on international medical graduates, threats to scientific independence, and updated AI publication guidelines. The episode also covers clinical pearls on liquid biopsies and celiac disease diagnosis.
Topics discussed
Introduction to Healthy Dialogue and episode overview
Lung cancer: Intensifying treatment for high-risk EGFR mutations
Anesthesia: Total intravenous vs. inhaled agents in surgery
Prostate cancer: SBRT vs. IMRT radiation therapy outcomes
Prostate cancer: Trends in focal therapy usage
Prostate cancer: Active surveillance adoption in veterans
Workforce: Role of international medical graduates in US care
Viewpoints: USPTF independence, public health regulation, and AI
Editorial: Updated guidance on AI use in JAMA publications
Clinical pearls: Liquid biopsies and circulating tumor DNA
Clinical pearls: Diagnosing and managing celiac disease
Conclusion, medical news summary, and copyright notice
Listen ad-free on Castria